Objective-Perivascular adipose tissue (PVAT) contains an independent adrenergic system that can take up, metabolize, release, and potentially synthesize the vasoactive catecholamine norepinephrine. Norepinephrine has been detected in PVAT, but the mechanism of its protection within this tissue is unknown. Here, we investigate whether PVAT adipocytes can store norepinephrine using VMAT (vesicular monoamine transporter). Approach and Results-High-performance liquid chromatography identified norepinephrine in normal male Sprague Dawley rat aortic, superior mesenteric artery, and mesenteric resistance vessel PVATs, and retroperitoneal fat. Real-time polymerase chain reaction revealed VMAT1 and VMAT2 mRNA expression in the adipocytes and stromal vascular fraction of mesenteric resistance vessel PVAT. Immunofluorescence demonstrated the presence of VMAT1 and VMAT2, and the colocalization of VMAT2 with norepinephrine, in the cytoplasm of adipocytes in mesenteric resistance vessel PVAT. A protocol was developed to capture real-time uptake of Mini 202-a functional and fluorescent VMAT probe-in live rat PVAT adipocytes. Mini 202 was taken up by freshly isolated and differentiated adipocytes from mesenteric resistance vessel PVAT and adipocytes from thoracic aortic and superior mesenteric artery PVATs. In adipocytes freshly isolated from mesenteric resistance vessel PVAT, addition of rose bengal (VMAT inhibitor), nisoxetine (norepinephrine transporter inhibitor), or corticosterone (organic cation 3 transporter inhibitor) significantly reduced Mini 202 signal. Immunofluorescence supports that neither VMAT1 nor VMAT2 is present in retroperitoneal adipocytes, suggesting that PVAT adipocytes may be unique in storing norepinephrine. Conclusions-This study supports a novel function of PVAT adipocytes in storing amines in a VMAT-dependent manner.
P erivascular adipose tissue (PVAT)-the tissue surrounding the vasculature-plays an undeniably important role in vascular health and disease. PVAT's intimate association with the vasculature allows it to be a powerful modulator of vascular tone and blood pressure through the uptake and release of vasoactive substances that, in health, exert a largely anticontractile effect on vessels. 1 Only recently did our understanding of PVAT evolve to encompass more than its function as a connective tissue between vessels. In 1991, Soltis and Cassis 2 discovered that the isolated rat thoracic aorta (TA) with the PVAT intact exhibits an increased contractile response to the indirect sympathomimetic tyramine and a decreased sensitivity to the catecholamine norepinephrine-a vasoconstrictor. A few studies since then have provided evidence for a functional adrenergic system residing within PVAT, independent from sympathetic nerves. [3] [4] [5] [6] [7] In 2011, Vargovic et al 3 made the discovery that mesenteric PVAT contains, and can likely synthesize, catecholamines, most notably norepinephrine.
Our previous studies demonstrate that PVAT adipocytes can take up, 5 metabolize, 6 and release 7 norepinephrine. Tetrabenazine-the classic VMAT (vesicular monoamine transporter) inhibitor-decreased tyramine-induced contraction in aorta and superior mesenteric artery with PVAT. 7 This raised the question: Can the PVAT adipocyte also store norepinephrine? We hypothesized that PVAT adipocytes do store norepinephrine and that they use the VMAT to do so, similar to sympathetic neurons. 8 A clearer understanding of the mechanism by which PVAT stores norepinephrine is crucial to fully appreciate the impact that PVAT's adrenergic system has on the vasculature. To test this hypothesis, PVATs from around the rat TA, superior mesenteric artery and vein (SMA/V), and mesenteric resistance vessels (MRV) of the mesenteric arcade were used: PVAT surrounding the thoracic aorta (APVAT), PVAT surrounding the SMA/V (SMPVAT), and PVAT surrounding the MRV (MRPVAT), respectively. These PVATs were chosen because the TA is an important conduit artery and the SMA/V is the gatekeeper to the MRV, which are model resistance vessels. 6, 7, 9 Furthermore, these 3 PVATs consist of different types of fat. APVAT is composed of adipocytes similar to those found in brown adipose tissue, MRPVAT of adipocytes similar to white adipocytes, and SMPVAT is a mixture of both. 10, 11 As a white PVAT adipocyte model (MRPVAT adipocytes) was used for our functional experiments, we predicted that VMAT is embedded in storage vesicles within the cytoplasm surrounding the large fat droplet and noncentral nucleus of the cell typical of a white adipocyte. 12 A multifaceted approach was used to test this hypothesis. High-performance liquid chromatography was used to measure norepinephrine content in fats, real-time polymerase chain reaction (RT-PCR) to detect VMAT mRNA in PVAT adipocytes and stromal vascular fraction (SVF), and immunofluorescence for VMAT and norepinephrine imaging. The MRPVAT was our primary focus of these studies. We developed a novel assay using Mini 202 to test whether norepinephrine uptake and storage in MRPVAT adipocytes is dependent on specific transporters. Mini 202 is a VMATspecific, pH-responsive fluorescent false neurotransmitter that has been used to demonstrate probe uptake in VMAT2-transfected human embryonic kidney cells and to measure the pH of catecholamine secretory vesicles in PC-12 (rat adrenal medulla pheochromocytoma) cells, which express VMAT1. 13 Importantly, Mini 202 uptake was investigated in multiple adipocytes, namely those freshly isolated from TA, SMA/V, and MRV, as well as MRPVAT adipocytes differentiated from precursor cells in MRPVAT SVF.
Our results support that a norepinephrine storage mechanism exists in the MRPVAT adipocyte and that it is VMAT dependent. These data help elucidate the independent adrenergic system within PVAT and set the stage for further research on how the obesity-related changes to this tissue can lead to hypertension.
Materials and Methods
The authors declare that all supporting data are available within the article (and its online-only Data Supplement).
Materials
The fluorescent false neurotransmitter, Mini 202, was purchased from Abcam (catalog ab120867; Cambridge, MA). Nisoxetine was purchased from Millipore-Sigma (catalog N151; Burlington, MA), and rose bengal (catalog 5168) and corticosterone (catalog 3685) were purchased from Tocris Bioscience (Bristol, United Kingdom). Unless stated, all other chemicals were purchased from MilliporeSigma. Please see the Major Resources Table in the online-only Data Supplement.
Animals
All protocols were approved by Michigan State University Institutional Animal Care and Use Committee. Normal male Sprague Dawley rats (Charles River, Indianapolis, IN) were used in accordance with the Guide for the Care and Use of Laboratory Animals (8th edition, 2011). The PVATs investigated have qualitatively and quantitatively similar magnitudes of catecholamine content when comparing specific tissues from male versus female. As such, the male was chosen as an overall model. The total number of rats used was 68. Rats were anesthetized with pentobarbital (80 mg/kg intraperitoneal), decapitated, exsanguinated, and tissues were removed. The fat located directly adjacent to the vessel was considered to be each respective PVAT (APVAT, SMPVAT, and MRPVAT) and was dissected in buffered solution with the aid of a stereomicroscope and micro scissors. Retroperitoneal fat was removed from behind the kidneys. Adrenal medullae dissection is expanded upon below.
High-Performance Liquid Chromatography
APVAT, SMPVAT, MRPVAT, and retroperitoneal fat tissues were homogenized in 4× their weight of 0.1 mol/L percholoric acid, centrifuged, and run through a 30-kDa filtration tube. The filtrates were analyzed on a high-performance liquid chromatography system with a Coulochem III electrochemical detector set at −300 mV (Thermo Fisher Scientific, Waltham, MA). Analytes were separated at 35°C on a HR-80 reverse-phase column (Thermo Fisher Scientific) with Catalog-A-Phase II (Thermo Fisher Scientific)-a mobile phase with a flow rate of 1.1 mL/min. Standards were run every fifth sample to confirm peak location on the chromatogram. The limit of detection for norepinephrine was 0.1 ng/mL. High-performance liquid chromatography data are reported as the mean±SEM norepinephrine content in each tissue.
RT-PCR
MRPVAT adipocytes and SVF were isolated from the PVAT as described previously.
14 Adrenal medullae and the locus coeruleus of the brain were used as positive controls for VMAT1 and VMAT2, respectively. The adipocytes and tissues were homogenized with an Omni Bead Ruptor (Omni, Inc, Kennesaw, GA) with the following parameters: 2 cycles for 30 s at speed 5.65 with 30-s delay between cycles, all at 6°C. RNA was extracted using the Quick RNA MiniPrep kit (catalog R1054; Zymo Research, Irving, CA Slides were coverslipped and subsequently imaged using a ×100 objective on a Nikon Eclipse TE2000 inverted microscope (Nikon Group, Otowara, Japan). Fluorescent images were captured using a Nikon Digital Sight DS-Qil camera and Nikon NIS Elements BR 3.00 software. Adjustments in brightness and contrast for all fluorescent images were applied uniformly across each image and relative to each sample's negative controls, using Photoshop CS6 v 13.0×64 (Adobe Systems, San Jose, CA). Images representative of at least 4 animals were selected for the figures.
Colocalization Immunofluorescence
The above protocol was followed with the following adjustments. Rat SMA/V+PVAT and MRV+PVAT were the experimental sections, and rat coronal brain and whole adrenal sections were used as positive controls. All sections were incubated in a species-specific blocking serum (1.5% rabbit serum in PBS-TX) for 60 minutes at room temperature. Experimental sections were then incubated with a VMAT2 primary antibody (goat; 1:100 in BS-TX; catalog NB100-1479; Novus Biologicals, Littleton, CO), whereas parallel sections were incubated in BS-TX, overnight at 4°C. 
Mini 202 Functional Experiments
This protocol was adapted for application in adrenal medulla chromaffin cells (Mini 202 positive control) and adipocytes from the procedure by Lee et al 13 (detailed in their online-only Data Supplement).
Adrenal Medulla Chromaffin Cells
The adrenal glands from 2 euthanized rats (8-12 weeks) were removed and transferred into dishes containing ice-cold dissec-
.5 mmol/L KH 2 PO 4 , 10 mmol/L glucose, 5 mmol/L HEPES free acid, and 14.2 mmol/L mannitol). The cortices were carefully trimmed away, and the isolated medullas were digested (2× 15 minutes at 37°C, oscillating) in 1 mL of enzyme solution containing 600 units papain (papain suspension; catalog LS003126; Worthington Biochemical, Lakewood, NJ), 500 µg BSA, and 150 µg dithiothreitol. The digested glands were then suspended in DMEM (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific) and triturated by a push-pull movement through a 1-mL pipette tip (10-15×). The solution was then spun at 1200×g for 2.5 minutes. The supernatant was discarded, the pellet resuspended in DMEM+10% FBS, and triturated again in a 200-µL pipette tip for better cell dissociation. Seventy-five microliters of cell suspension were plated in wells of a collagen IV-coated 8-well chamber slide (µ-Slide 8 well; catalog 80822; Ibidi, Planegg, Germany), and 125 µL DMEM+10% FBS was added to each well. Cells were incubated (90 minutes at 37°C, 5% CO 2 ) to allow for settling and attachment. Mini 202 (500 µmol/L) was added to 1 well and incubated for 60 minutes. Solutions were then aspirated and cells washed 3× with DMEM+10% FBS. Two-hundred microliters DMEM+10% FBS were added to each chamber, and cells were imaged using a ×40 objective and the same microscope, camera, and software described previously. Mini 202 signal was visible in the DAPI channel with a SOLA light engine (Lumencor, Inc, Beaverton, OR).
Adipocytes

MRPVAT Adipocytes
The mesenteries were removed from 2 euthanized rats (350-430 g in weight) and tissues pooled to constitute a biological n=1. Mesenteries were cut into 3 to 4 pieces, and the intestinal contents were evacuated from the intestine to avoid contamination of the PVAT. Tissues were kept and dissected in chilled Krebs-Ringer bicarbonate buffer (KRBB; 135 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgSO 4 , 0.4 mmol/L K 2 HPO 4 , 5.5 mmol/L glucose, 20 mmol/L HEPES, 10 mL antibiotic/antimycotic; pH to 7.4). MRPVAT was dissected from around the MRV using a stereomicroscope and collected in chilled KRBB. 14 Dissected PVAT was added to tubes with 1 mL of warmed digestion solution containing 1 mg of collagenase (collagenase type I; catalog LS004196; Worthington Biochemical) and 4% BSA (catalog A2153; Sigma) in KRBB. Small scissors were used to mince the tissue. The samples were then placed at 37°C in a rotating incubator at low speed for 60 minutes or until the solution appeared milky and no large PVAT fragments were visible. The tubes were centrifuged at 200×g for 5 minutes, and the SVF that pelleted to the bottom was discarded. Adipocytes were washed 3× with 1 mL of warm wash solution (4% BSA in KRBB). All adipocytes were then combined and the total volume measured.
For adipocytes from MRPVAT, this volume was evenly split among three 1.5-mL tubes. Vehicle and KRBB were added to the first and second tubes. Inhibitor (100 µmol/L rose bengal, 15 VMAT; 1 µmol/L nisoxetine, NET; or 1 mmol/L corticosterone, OCT3) and KRBB were added to the third tube. For all incubations in the nisoxetine experiments, the KRBB in each condition contained 1% BSA to aid in inhibitor suspension and delivery to the cell. All tubes were incubated for 30 minutes at 37°C with rotation. Mini 202 (500 µmol/L) was added to the second and third tubes, and all tubes were further incubated for 60 minutes in the dark. A concentration of 500 µmol/L Mini 202 was selected because it produced consistent signal while avoiding camera saturation. All cells were centrifuged and washed with wash solution 3×, as before. Twenty microliters of adipocytes were then plated on an uncoated Ibidi µ-slide Angiogenesis slide (catalog 81506; Ibidi) and imaged as described for chromaffin cells. The full experimental protocol is depicted in Figure 1 .
The unadjusted fluorescent TIFF images were quantified on Image Studio (LI-COR Biosciences, Lincoln, NE) in duplicate by 2 independent researchers. Two concentric circles were drawn to enclose the signal around the edge of each cell and to set the inside of each cell as its own baseline because of the varying background intensities of floating cells. Two independent researchers quantified all cells in the images that were in focus with consistent methods as their overall means did not differ significantly. Each researcher's mean of the arbitrary signal intensities (SIs) for each condition was calculated per experiment. These means were then averaged with their pairs to obtain 4 means (n=4) per condition. The images selected for display were representative of all (biological n=4) images in that treatment condition.
TA and SMA/V Adipocytes
In a separate experiment using adipocytes isolated from MRPVAT (for comparison), TA, and SMA/V PVAT, incubation with Mini 202 (500 µmol/L) was performed compared with a vehicle control so as to determine the generality of Mini 202 uptake between adipocytes isolated from different vessels. Isolation and staining occurred exactly as described above. Cellular images were captured and analyzed on the Nexcelom Cellometer Vision (Nexcelom Bioscience, Lawrence, MA) with the 450-302 cube. In these same cells, the viability of the adipocytes was assessed by uptake of the nucleic acid binding dyes acridine orange and propidium iodide (Cellometer acridine orange propidium iodide No. CS2-0106; Nexcelom Bioscience). Acridine orange is cell permeable (nuclear), and propidium iodide will only enter a cell with a compromised membrane, or an unhealthy/dying, dead or necrotic cells. Adipocytes from these experiments were imaged using the Cellometer Vision, 535-402 cube, 660-502 cube, and data analyzed using Cellometer Vision software, v.2.1.10.11.
Adipocytes Differentiated From MRPVAT SVF
Preadipocytes were obtained from MRPVAT SVF after 2 serial passages in culture flasks (Nest Biotechnology, Rahway, NJ) as reported. 16 Expanded preadipocyte populations were seeded in 24-well plates (Corning) at a concentration of 20 000 cells/cm 2 and allowed to proliferate to confluency. Preadipocytes were then induced to differentiate using standardized adipogenic media while in coculture with primary MRPVAT adipocytes (900 cells per cm 2 ) contained in a 0.4 µm trans-well insert (Greiner Bio-One). 16 Primary adipocytes were removed after 5 days of coculture, and differentiated cultured adipocytes were used 2 days later for Mini 202 functional experiments. Cells were imaged as described above for chromaffin cells.
Immunocytochemistry
MRPVAT adipocytes and corresponding SVFs were isolated as stated above. For CD68 staining, cells were incubated for 1 hour at 37°C with mouse anti-rat CD68 (1:50, No. MCA341; Bio-Rad, Hercules, CA), washed 3× (4% BSA in KRBB), and incubated for 30 minutes at 37°C with goat anti-mouse Alexa Fluor 488 (1:1000, A11029; Thermo Fisher Scientific). After 2 additional washes (4% BSA in KRBB), cells were loaded into the Cellometer Vision and images captured with the 535-402 cube and brightfield microscopy. Fluorescent images (raw 8-bit) were imported to ImageJ v.1.48a, thresholded to remove background, colorized to red, and overlaid on the corresponding brightfield image to view colocalization with adipocytes.
MR, TA, and SMA/V adipocytes were isolated as stated above. Cells were incubated with 1 mg/mL of WGA Alexa Fluor-555 (W32464; Thermo Fisher Scientific) for 10 minutes at 37°C. After 2 washes (4% BSA in KRBB), cells were imaged on the Cellometer Vision with the 595-502 cube. In copies of these images, brightness was enhanced for better visibility.
Differentiated adipocytes were isolated as described above. Cells were fixed with 4% paraformaldehyde in PBS overnight then washed once with PBS. Cells were then stained for VMAT1 and VMAT2 as stated above in the Immunofluorescence section.
To stain lipid, fixed cells were treated with the neutral lipid stain HCS LipidTox (H34477; Life Technologies, Carlsbad, CA) using 300 μL of a 1:1000 dilution per cm 2 of tissue culture area. For counterstaining, NucBlue (R37605; Thermo Scientific) was used following manufacturer's instructions.
Statistical Analyses
All values reported represent means±SEM for the number of biological replicates represented by n. Variables were tested for normality (Kolmogorov-Smirnov) and homogeneity of variances before application of the appropriate statistical test.
High-Performance Liquid Chromatography
The equality of the variances for the mean values was verified with the Bartlett test after an arcsine transformation to account for the nonGaussian retroperitoneal fat data. A 1-way ANOVA with post hoc Bonferroni test was performed on these values, and a P <0.05 was considered statistically significant. The graph of these data represents actual norepinephrine content in nanogram per gram of tissue, but statistical significance is the same as for the transformed values.
Mini 202 Experiments+Inhibitors
These data were transformed by adding the absolute value of the lowest mean to all other means to account for the several negative SI found in the vehicle and inhibitor conditions (when the background of the well was often brighter than the perimeter of the cell itself). The equality of the variances for the resulting mean values was verified with the Brown-Forsythe test. A 1-way ANOVA with post hoc Bonferroni test was then used to determine statistical significance between conditions. The data are presented as mean±SEM arbitrary SIs, with a P <0.05 considered statistically significant.
Results
PVATs Contain Norepinephrine
High-performance liquid chromatography was used to measure norepinephrine content in the PVATs surrounding the TA (APVAT), SMA/V (SMPVAT), and the MRV of the mesenteric arcade (MRPVAT). Figure 2 shows that all 3 PVATs contain notable levels of norepinephrine (APVAT=739.98±15.78 ng/g tissue; SMPVAT=364.72±44.06 ng/g tissue; and MRPVAT=96.17±23.90 ng/g tissue), although content varies significantly between all PVATs. Norepinephrine is also detectable in retroperitoneal fat (44.104±3.89 ng/g tissue) but at a lower concentration than it is in PVAT tissues. These data support that norepinephrine is present in PVAT. The PVAT adipocyte was the logical place to begin investigating a potential norepinephrine storage mechanism.
Mesenteric PVATs and PVAT Adipocytes Contain VMAT; Retroperitoneal Fat Does Not
Polymerase Chain Reaction mRNA for VMAT1 and VMAT2 was detected at low but measurable levels in MRPVAT adipocytes and in SVF from the same PVAT (Table 1 ). The positive controls for VMAT1 (adrenal; cycle threshold value, 24.46) and VMAT2 (locus coeruleus; cycle threshold value, 26.95) validated proper detection of gene expression using these primers (Table 1) . In a separate experiment using MRPVAT adipocytes only and performed by a different individual than was responsible for the data in Table 1 , we observed a similar outcome (β-actin=19.11±0.5; VMAT1=36.72±0.71; VMAT2=33.98±0.32; n=4-5). We attempted Western analyses to compare the relative expression of these 2 VMAT proteins but were unsuccessful in procuring an antibody that could detect VMAT at the expected molecular weight. Thus, we turned to immunohistochemistry for which antibodies have been successfully developed for VMAT localization.
Immunofluorescence
For norepinephrine to be detectable, it must be protected in the cell. We hypothesize norepinephrine is stored in vesicles within the cytoplasm through VMAT as this is how sympathetic neurons store norepinephrine. Immunohistochemical staining revealed APVAT, SMPVAT, and MRPVAT contain VMAT1 ( Figure 3A ) and VMAT2 ( Figure 3B ). Positive staining for both these transporters is present surrounding the lipid of the adipocytes. In adipocytes differentiated and cultured from adipocyte precursors found in MRPVAT SVF, VMAT1, and VMAT2, staining can also be seen in the cytoplasm of the cell ( Figure 3C ). Interestingly, results indicate the absence of VMAT1 ( Figure 3A ) and VMAT2 ( Figure 3B ) from retroperitoneal fat. Staining in rat adrenal medulla chromaffin cells and in the anterior commissure of the rat brain verified our ability to visualize VMAT1 and VMAT2, respectively, in the aforementioned tissues. Arrows point to areas of intense staining, many sites of which are near the nucleus. We have not stained for other organelles, so the precise cellular location of VMAT cannot be determined. Normalization of VMAT to ACTB is expressed as 2 −delta CT . Representative of 4 different rats. C T indicates threshold cycle. Adrenal and locus coeruleus (LC) were used as positive controls. β-actin (ACTB) was the housekeeping gene. VMAT indicates vesicular monoamine transporter.
VMAT2 and Norepinephrine Colocalize in Mesenteric PVATs
The higher expression of VMAT2 than VMAT1 mRNA in MRPVAT adipocytes directed the focus to VMAT2 for these colocalization experiments. Immunofluorescence experiments with antibodies against VMAT2 and norepinephrine demonstrated their colocalization in SMPVAT and MRPVAT. Arrows point to yellow signal in Figure 4 , indicating areas of colocalization of VMAT2 and norepinephrine. The caudate putamen region of the rat brain was used as a positive control, and colocalization in this tissue can be observed mainly around the nuclei. Macrophages, as stained by CD68, were not significantly associated with isolated adipocytes ( Figure I in the online-only Data Supplement) and thus are an unlikely source of norepinephrine. These data thus far indicate that the PVAT adipocyte may be capable of storing norepinephrine via VMAT. Functional experiments were next performed in the isolated PVAT adipocyte to test this idea.
Inhibitors of Plasma Membrane Transporters and VMAT Decrease Mini 202 Uptake in MRPVAT Adipocytes
Adrenal Medulla Chromaffin Cells Chromaffin cells were isolated from rat adrenal medullae and used as a positive control for Mini 202 uptake. As shown in Treatment with the transporter inhibitors reduced this fluorescence. Figure 5C depicts 
Discussion
This is the first study to reveal VMAT presence and function in PVAT adipocytes. Taken together, these data provide evidence for a norepinephrine storage mechanism in the PVAT adipocyte. This mechanism involves norepinephrine uptake into the cell through the plasma membrane transporters NET and OCT3. Once in the cytosol, norepinephrine is taken up through VMAT for storage in vesicles ( Figure 6 ).
Our data support previous findings that PVAT contains functional catecholamines. 7 The analyzed PVATs contained norepinephrine, with APVAT and SMPVAT having >7 and 3× more norepinephrine than MRPVAT, respectively (Figure 2 ). Although MRPVAT contains the least amount of norepinephrine of these PVATs, the functional experiments in this study were performed with these adipocytes because the MRV, being model resistance vessels, directly impacts total peripheral resistance and thus blood pressure. 9, 17 Additionally, studies have shown positive correlation between increased visceral fat, like MRPVAT, and hypertension and cardiovascular risk. [18] [19] [20] There are several reasons why the norepinephrine content of these tissues could be different from one another. The TA-PVAT, as a brown fat, was expected to be high in norepinephrine concentration given that brown fat is considered to be thermogenically driven by the sympathetic nervous system. 21 However, the TA itself is considered to be poorly innervated by the sympathetic nervous system 22 and has poor responses to electrical field stimulation. 23 This suggests that brown fat maintains catecholamine content either through synthesis or uptake from exogenous sources. In contrast, the retroperitoneal fat had a substantially lower norepinephrine content, yet is known to be innervated by the sympathetic nervous system. 24 The magnitude of norepinephrine in SMPVAT is in between that of APVAT and retroperitoneal fat. We have demonstrated that denervation of this tissue by celiac ganglionectomy did not abolish norepinephrine content. 7 Collectively, this evidence suggests it is more likely a property of the fat itself, as opposed to innervation, that influences final norepinephrine content. Norepinephrine content could also be different between these tissues because of increased activity of norepinephrine metabolizing enzymes. Oxidases such as monoamine oxidase (MAO), but more so semicarbazide-sensitive amine oxidase (SSAO), are expressed in MRPVAT, 6 specifically in the adipocytes of these tissues. SSAO was more highly expressed and functional in the MRPVAT versus MAO in an amine oxidase activity assay. MAOA and MAOB were virtually inactive in MRPVAT and MRPVAT adipocytes. If this is consistent between fats, SSAO expression and function could influence norepinephrine concentration. However, incubation of tissues with the SSAO inhibitor semicarbazide did not increase norepinephrine content in the TA or MRPVAT PVATs (not shown). Although we have not done the comparative measures of SSAO expression and activity between the 3 PVATS-aortic, superior mesenteric, and mesenteric resistance-and thus cannot exclude the possibility that oxidases may contribute to the different concentration of norepinephrine in these tissues, our findings suggest the difference in norepinephrine concentration between fats is intrinsic to each PVAT.
The SMPVAT has smaller and more brown or multilocular adipocytes than MRPVAT, which is more flocculent and white in appearance. Macroscopically, MRPVAT resembles retroperitoneal fat. However, this study determined that although retroperitoneal fat contains norepinephrine (Figure 2 ), unlike PVAT, it does not contain VMAT1 or VMAT2 (Figure 3) . Adipose tissues that are high in catecholamine content (APVAT and brown fat pad) are also positive for the brown adipose marker UCP1 (uncoupling protein 1).
11 These findings suggest that adipose tissues high in norepinephrine have more brown adipocyte-like characteristics and those with low norepinephrine content are more similar to white adipose tissue adipocytes.
MRPVAT adipocytes separated from the other components of PVAT contain norepinephrine. 5 Norepinephrine content in PVAT occurs because of uptake of exogenous norepinephrine and may also be attributed to endogenous norepinephrine synthesis, as others have reported adipose tissue adipocytes as a potential source of catecholamine synthesis. 3 Macrophages have recently gained attention as cell types able to catabolize 25, 26 but not synthesize 27 norepinephrine. In our hands, CD68-positive cells are rarely associated with adipocytes and likely do not account for significant amounts of the norepinephrine measured in PVAT. Fischer et al 27 concluded that "…macrophages do not synthesize relevant amounts of catecholamine, and hence are not likely to have a direct role in adipocyte metabolism or adaptive thermogenesis." It remains to be seen whether the uptake of exogenous norepinephrine or catabolism of norepinephrine by the macrophage could influence lipolysis-an end point that was not the focus of this work.
Rat APVAT and MRPVAT adipocytes can take up norepinephrine. 5 OCT3 is involved in the uptake of norepinephrine into PVAT adipocytes in the rat 5 and in human brown adipose tissue biopsies. 28 In the present study, Mini 202 signal was present, supporting the function of VMAT in these tissues. Importantly, uptake of Mini 202 was observed not just in the adipocytes from MRPVAT but also from TA and SMA/V PVAT adipocytes and adipocytes that underwent no collagenase digestion (cultured adipocytes). Collectively, these experiments support that there is a potential to store catecholamines in each of these adipocytes.
Mini 202 staining was inhibited by the OCT3 inhibitor corticosterone and the NET inhibitor nisoxetine ( Figure 5B and 5C). This suggests that Mini 202 enters the cell through OCT3 and NET, and inhibiting entry through these transporters prevents its later interaction with VMAT. In MRPVAT, nisoxetine can completely inhibit the anticontractile effect that PVAT has on MRV suggesting that PVAT acts as a sink for exogenous norepinephrine. Interestingly, both were located in SMPVAT and MRPVAT (Figure 3 ). The localization of the transporters in different tissues is species dependent. However, mechanisms of norepinephrine uptake through OCT3 are conserved between the rat and human. 5, 28 Although the amine 5-hydroxytryptamine has a similar affinity for VMAT1 and VMAT2, the catecholamines dopamine, norepinephrine, and epinephrine have a 3-fold higher affinity for VMAT2. 29, 30 The uptake efficiencies of these amines by VMAT2 are as follows: 5-hydroxytryptamine>dopamine>epinephrine>nore pinephrine. 29 Before this study, little was known about VMAT in adipose tissue. 3T3-L1 adipocytes were recently discovered to express VMAT1, suggesting adipocytes have the ability to store amines.
14 Furthermore, 3T3-L1 adipocytes can take up norepinephrine.
14 However, tyramine (which causes the release of amines from intracellular stores through reverse transport) was unable to stimulate norepinephrine release, probably related to the finding that 3T3-L1 adipocytes do not express the plasma membrane transporters which are necessary for tyramine's function.
14 In contrast to 3T3-L1 adipocytes, rat MRPVAT adipocytes contain basal levels of norepinephrine and express OCT3. 5, 14 Addition of tyramine on MRPVAT and APVAT causes the release of norepinephrine, dopamine, and 5-hydroxytryptamine from the tissue, 7 different from what was observed in 3T3-L1 adipocytes.
14 Tyramine-stimulated release of catecholamines results in contraction of the isolated rat aorta and mesenteric artery only when the associated PVAT is left intact. Furthermore, tyramine's effect on contraction remained even after the neuronal innervation to the mesentery was removed by celiac ganglionectomy. 7 Addition of the VMAT inhibitor tetrabenazine reduced the maximal contraction to tyramine of the rat aorta with PVAT. 7 Together, those studies suggested that tyramine's effect was PVAT and VMAT dependent but nerve independent.
PVAT contains cells other than neurons that could have functional VMATs and store norepinephrine. Human monocyte-derived macrophages express mRNA for DAT and VMAT2. 31 Mouse perivascular macrophages also express SERT. 32 However, the colocalization of VMAT2 with norepinephrine by confocal microscopy under high power clearly shows their presence in the cytoplasm of the PVAT adipocyte and not in other cells (Figure 4) . Similarly, the minimal stickiness of the macrophage to the isolated adipocytes suggests macrophages are not an important contributor of norepinephrine to the measures made.
We recognize that VMAT staining within the capillaries of the PVAT could compromise part of the staining observed, although a tissue like retroperitoneal fat, which possesses capillaries, did not stain for VMAT1 or VMAT2. This is why experiments with the isolated adipocytes were critical, and they support both Mini 202 uptake and staining for VMAT1 and VMAT2 in these cells.
Technical Comments
The ability to conduct a functional assay with primary isolated MRPVAT adipocytes presented specific challenges. One reason for this is that primary adipocytes are fragile and prone to lysis once removed from their tissue matrix. Experiments ex vivo with adipocytes have to be done quickly after isolation and with minimal manipulation of the adipocytes to prolong their health. Because of these limitations, functional assays are sometimes replaced with the use of adipocyte cell line models, such as 3T3-L1 mouse embryonic fibroblasts that are differentiated in vitro into cells that accumulate lipid and thus mimic adipocytes. We were able to do such experiments with a significant portion (≈65%) of cells viable at the time of experimentation.
Another way to study adipocyte biology is by the isolation of primary preadipocytes that are then differentiated in culture to adipocytes before they are studied, and this is precisely what was done with adipocytes differentiated from the SVF of MRPVAT. The functional assays performed in this study used either primary PVAT adipocytes or adipocytes differentiated from SVF. The qualitatively similar finding of Mini 202 uptake by these adipocytes added confidence in the findings that VMAT is present in PVAT adipocytes and is functional.
Limitations
There is evidence to support that Mini 202 has reasonable specificity to VMAT1 and VMAT2. Mini 202 is a substrate of VMAT1 (PC-12 cells) and VMAT2 tested in human embryonic kidney cells stably expressing VMAT2. 13 Furthermore, Mini 202 staining was inhibited by reserpine in PC-12 (rat pheochromocytoma) cells and by reserpine and tetrabenazine in VMAT2 expressing human embryonic kidney cells. 13 Transmission electron microscopy would be the preferred method for norepinephrine/VMAT2 colocalization because it would allow for the visualization of the vesicles. However, because of the high lipid content of adipocytes and equipment limitations, transmission electron microscopy could not be pursued for this study. In our experiments, we inhibited Mini 202 uptake with rose bengal-an inhibitor of VMAT2 (IC 50 =64 nmol/L for 5-hydroxytryptamine uptake). Rose bengal also inhibits the VGLUT (vesicular glutamate transporter) with an IC 50 of 25 nmol/L and the VAChT (vesicular acetylcholine transporter; another member of the solute carrier family 18) with an IC 50 of >9700 nmol/L. 15 VGLUT1 has been reported to be present in brown and white adipose tissue adipocytes. 33 VAChT expression in adipocytes has not been reported and neither has the ability of Mini 202 to bind VGLUT. Thus, it is possible that the Mini 202 uptake observed could be from Mini 202 binding at VGLUT, which is inhibited by rose bengal. We were unable to use the VMAT inhibitor tetrabenazine in our experiments because of the requirement that the drug be dissolved in 100% ethanol, which decreased the viability of the adipocytes during the experimental protocol.
Comparison of the ability of Mini 202 to enter adipocytes of mice lacking VMAT could be a future experiment. There are limitations to genetic VMAT knockout models because VMAT2 −/− mice die a few days after birth. 34, 35 The heterozygous mice survive but have reduced brain catecholamines. 34, 35 In vivo imaging of VMAT activity in adipocytes by [ 11 C]tetranbenazine labeling combined with PET imaging 36 could be another way that VMAT function in adipocytes can be investigated.
It is possible that concentration by VMAT into vesicles is not the only mechanism by which adipocytes store norepinephrine. Exosomes isolated from adipocytes from visceral adipose tissue were recently found to be involved in intercellular signaling leading to liver pathogenesis. 37 Perhaps norepinephrine can also be packaged into exosomes or other extracellular vesicles for downstream effects on the vasculature.
Disease Relevance of the Findings
Why do adipocytes store norepinephrine? PVAT adipocytes have high activity of the semicarbazide-sensitive amine oxidase. 6 Thus, norepinephrine that is taken up into adipocyte vesicles would be protected from oxidation. Because norepinephrine is important for the induction of lipolysis of adipocytes, 38 storage of norepinephrine by the adipocyte and then release could be a way that adipocytes self-regulate lipolysis. It is interesting to consider the impact of these findings in disease. Adipocyte biology is dysregulated in obesity. 39 If norepinephrine storage in adipocytes is impaired in obesity, less norepinephrine would be available for lipolysis. Measures of lipolysis-as an end point that could be affected by adipocyte stored norepinephrine-are beyond the scope of the intended study. However, the findings that adipocytes store norepinephrine remain to be investigated in obesity. Because PVAT is important for blood vessel function because it regulates its contractility and affects the inflammation of the vasculature, alterations in norepinephrine uptake and storage could also have profound effects on vascular tone. 40 A decrease in adipocyte uptake and storage of norepinephrine could increase contraction of vessels, thereby potentially increasing blood pressure.
Conclusions
The adrenergic system within the adipocyte has resemblances to that system best known in sympathetic neurons. Within the adipocytes exist mechanisms to synthesize, take up, metabolize, and release norepinephrine. 3, [5] [6] [7] We provide novel data supporting another adrenergic mechanism present in the adipocyte: norepinephrine storage through VMAT. These findings have large implications for the understanding of adipocyte and vascular biology. The question remains whether these mechanisms contribute to high blood pressure alterations in diseases such as obesity.
